Journal article
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
Abstract
AIMS: The curiosity that leanness is associated with poor survival in patients with chronic heart failure (CHF) needs further insight by investigating the impact of weight loss on prognosis in a large sample of patients across a broad spectrum of both reduced and preserved left ventricular (LV) systolic function.
METHODS AND RESULTS: We investigated the change in weight over 6 months in 6933 patients in the Candesartan in Heart failure: …
Authors
Pocock SJ; McMurray JJV; Dobson J; Yusuf S; Granger CB; Michelson EL; Östergren J; Pfeffer MA; Solomon SD; Anker SD
Journal
European Heart Journal, Vol. 29, No. 21, pp. 2641–2650
Publisher
Oxford University Press (OUP)
Publication Date
11 2008
DOI
10.1093/eurheartj/ehn420
ISSN
0195-668X